ALSERES PHARMACEUTICALS INC /DE

Alseres Pharmaceuticals Inc /DE (CIK 94784) is a Delaware-registered specialty pharmaceutical concern whose operations center on developing and positioning small-molecule therapeutics and clinical formulation services aimed at hospital systems and specialty pharmacies that manage complex patient cohorts. The company marries in-house research with partnership-enabled manufacturing to move compounds through IND programs, giving a nod to the broader SIC 2834/2836 universe covering pharmaceutical preparations and diagnostic substances even though an exact code is not publicly highlighted. While the latest SEC filing remains unpublished, managers continue to signal reliance on milestone-driven collaborations and service contracts for revenue, underscoring the pivotal material risks tied to regulatory approvals, drug-safety surveillance and the cyclicality of payer coverage rules overseen by the FDA and other healthcare regulators. Governance and reporting rigor are maintained through standard SEC disclosure channels, and infrastructure investments keep compliance-ready data trails intact—view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025